Join
Live feed
·
PRReleasevia Quantisnow
Sanofi logo
Principia Biopharma Inc. logo

Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib

ByQuantisnow·Wall Street's wire, on your screen.
SNY· SanofiPRNB· Principia Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNY (Sanofi), PRNB (Principia Biopharma Inc.) and more on Quantisnow.